Granted Patent B2

US 12,569,688 · App. 18/054,137 · Granted Mar 10, 2026

Inventors: Xusheng Zhang (Shoreview, MN); Saul E. Greenhut (Denver, CO); Yuanzhen Liu (Palo Alto, CA); Alfonso Aranda Hernandez (Minneapolis, MN); Michael W. Heinks (New Brighton, MN); Jean E. Hudson (Blaine, MN); Timothy A. Ebeling (Circle Pines, MN); Irving J. Sanchez (Blaine, MN); Scott R. Hawkinson (Andover, MN); Troy E. Jackson (Rogers, MN); James Vander Heyden (Delano, MN)

Assignee: Medtronic, Inc.

A61N1/362A61B5/363A61N1/36507

Abstract

Claims (149)

1 . A medical device comprising:

a sensing circuit configured to sense at least one cardiac electrical signal;

a therapy delivery circuit configured to deliver cardiac pacing pulses; and

a control circuit in communication with the sensing circuit and the therapy delivery circuit, the control circuit configured to:

schedule a pending pacing pulse of the cardiac pacing pulses by starting a first pacing escape interval;

receive a first cardiac signal segment from the at least one cardiac electrical signal sensed by the sensing circuit during the first pacing escape interval;

determine tachyarrhythmia evidence in the first cardiac signal segment by determining at least one tachyarrhythmia morphology metric from the first cardiac signal segment; and

delay the pending pacing pulse scheduled at an expiration of the first pacing escape interval in response to determining the tachyarrhythmia evidence in at least the first cardiac signal segment.

2 . The medical device of claim 1 , wherein:

the sensing circuit is further configured to sense cardiac event signals from the at least one cardiac electrical signal;

the control circuit is further configured to schedule the pending pacing pulse by starting the first pacing escape interval in response to the sensing circuit sensing a cardiac event signal.

3 . The medical device of claim 1 , wherein the control circuit is further configured to schedule the pending pacing pulse by starting the first pacing escape interval in response to the therapy delivery circuit delivering a cardiac pacing pulse.

4 . The medical device of claim 1 , wherein the control circuit is further configured to delay the pending pacing pulse by restarting the first pacing escape interval.

5 . The medical device of claim 1 , wherein the control circuit is further configured to delay the pending pacing pulse by starting a pacing delay interval different than the first pacing escape interval.

6 . The medical device of claim 1 , wherein the control circuit is further configured to:

receive a plurality of cardiac signal segments including the first cardiac signal segment from the at least one cardiac electrical signal;

determine tachyarrhythmia evidence in at least a threshold number of the plurality of cardiac signal segments; and

delay the pending pacing pulse in response to determining the tachyarrhythmia evidence in at least the threshold number of the plurality of cardiac signal segments.

7 . The medical device of claim 1 , wherein the control circuit is further configured to determine the tachyarrhythmia evidence in the first cardiac signal segment by:

identifying signal pulse peaks from the first cardiac signal segment;

determining peak intervals between the identified signal pulse peaks; and

determining that the peak intervals meet a tachyarrhythmia rate threshold.

8 . The medical device of claim 1 , wherein the control circuit is further configured to determine the tachyarrhythmia evidence in the first cardiac signal segment by:

determining at least one of:

a low slope content from the first cardiac signal segment;

a spectral width from the first cardiac signal segment; and

a mean period from the first cardiac signal segment;

determining that at least one of the low slope content, the spectral width and the mean period meet tachyarrhythmia evidence criteria; and

determining the tachyarrhythmia evidence in the first cardiac signal segment in response to the at least one of the low slope content, the spectral width and the mean period meeting the tachyarrhythmia evidence criteria.

9 . The medical device of claim 1 , wherein the control circuit is further configured to determine the tachyarrhythmia evidence in the first cardiac signal segment by:

determining a spectral width from the cardiac signal segment;

determining a mean period from the cardiac signal segment;

determining that the mean period meets a first threshold;

determining that a ratio of the spectral width and the mean period meets a second threshold; and

determining the tachyarrhythmia evidence in the first cardiac signal segment based on the mean period meeting the first threshold and the ratio of the spectral width and the mean period meeting the second threshold.

10 . The medical device of claim 1 , wherein:

the control circuit is further configured to:

receive a second cardiac signal segment from the at least one cardiac electrical signal sensed by the sensing circuit after delaying the pending pacing pulse; and

determine no tachyarrhythmia evidence in the second cardiac signal segment; and

the therapy delivery circuit is further configured to deliver the delayed pending pacing pulse in response to the control circuit determining no tachyarrhythmia evidence in at least the second cardiac signal segment.

11 . The medical device of claim 1 , wherein:

the control circuit is further configured to:

receive a second cardiac signal segment from the at least one cardiac electrical signal sensed by the sensing circuit;

determine an amplitude metric from the second cardiac signal segment;

determine that the amplitude metric is less than an amplitude threshold; and

determine no tachyarrhythmia evidence in the second cardiac signal segment in response to the amplitude metric being less than the amplitude threshold; and

the therapy delivery circuit is further configured to deliver the delayed pending pacing pulse in response to the control circuit determining no tachyarrhythmia evidence in at least the second cardiac signal segment.

12 . The medical device of claim 1 , wherein:

the control circuit is further configured to:

receive a second cardiac signal segment from the at least one cardiac electrical signal sensed by the sensing circuit;

determine at least one noise metric from the second cardiac signal segment; and

determine no tachyarrhythmia evidence in the second cardiac signal segment based on the at least one noise metric; and

the therapy delivery circuit is further configured to deliver the delayed pending pacing pulse in response to the control circuit determining no tachyarrhythmia evidence in at least the second cardiac signal segment.

13 . The medical device of claim 1 , wherein the control circuit is further configured to:

delay the pending pacing pulse by setting a first delay interval in response to determining tachyarrhythmia evidence in at least the first cardiac signal segment;

receive a second cardiac signal segment from the at least one cardiac electrical signal sensed by the sensing circuit during the first delay interval;

determine tachyarrhythmia evidence in the second cardiac signal segment; and

delay the pending pacing pulse by setting a second delay interval in response to determining the tachyarrhythmia evidence in at least the second cardiac signal segment.

14 . The medical device of claim 1 , wherein:

the therapy delivery circuit is further configured to deliver a plurality of pacing pulses; and

the control circuit is further configured to:

start a plurality of pacing escape intervals comprising the first pacing escape interval, wherein each pacing escape interval of the plurality of pacing escape intervals is started in response to the therapy delivery circuit delivering a pacing pulse of the plurality of pacing pulses;

receive a plurality of cardiac signal segments comprising the first cardiac signal segment from the at least one cardiac electrical signal, wherein the plurality of cardiac signal segments are sensed by the sensing circuit during the plurality of pacing escape intervals;

determine tachyarrhythmia evidence in the plurality of cardiac signal segments; and

delay the pending pacing pulse scheduled at the expiration of the first pacing escape interval in response to determining the tachyarrhythmia evidence in the plurality of cardiac signal segments.

15 . The medical device claim 1 , wherein:

the control circuit is further configured to determine that a maximum pacing delay of the pending pacing pulse is reached; and

the therapy delivery circuit is configured to deliver the pending pacing pulse in response to the maximum pacing delay being reached.

16 . The medical device of claim 1 , wherein the control circuit is further configured to determine the tachyarrhythmia evidence without detecting a tachyarrhythmia based on the first cardiac signal segment.

17 . The medical device of claim 1 , wherein:

the control circuit is further configured to:

detect a tachyarrhythmia from the at least one cardiac electrical signal after delaying the pending pacing pulse; and

cancel the pending pacing pulse in response to detecting the tachyarrhythmia; and

the therapy delivery circuit is further configured to deliver a tachyarrhythmia therapy in response to the control circuit detecting the tachyarrhythmia.

18 . A method comprising:

sensing at least one cardiac electrical signal;

scheduling a pending pacing pulse for delivery by a therapy delivery circuit by starting a first pacing escape interval;

receiving a first cardiac signal segment from the at least one cardiac electrical signal sensed during the first pacing escape interval;

determining tachyarrhythmia evidence in the first cardiac signal segment by determining at least one tachyarrhythmia morphology metric from the first cardiac signal segment; and

controlling the therapy delivery circuit to delay the pending pacing pulse scheduled at an expiration of the first pacing escape interval in response to determining the tachyarrhythmia evidence in at least the first cardiac signal segment.

19 . The method of claim 18 , further comprising:

sensing cardiac event signals from the at least one cardiac electrical signal; and

scheduling the pending pacing pulse by starting the first pacing escape interval in response to sensing a cardiac event signal from the cardiac electrical signal.

20 . The method of claim 18 , further comprising:

delivering a cardiac pacing pulse; and

scheduling the pending pacing pulse by starting the first pacing escape interval in response to delivering the cardiac pacing pulse.

21 . The method of claim 18 , further comprising delaying the pending pacing pulse by restarting the first pacing escape interval.

22 . The method of claim 18 , further comprising delaying the pending pacing pulse by starting a pacing delay interval different than the first pacing escape interval.

23 . The method of claim 18 , further comprising:

receiving a plurality of cardiac signal segments including the first cardiac signal segment from the at least one cardiac electrical signal;

determining tachyarrhythmia evidence in at least a threshold number of the plurality of cardiac signal segments; and

delaying the pending pacing pulse in response to determining the tachyarrhythmia evidence in at least the threshold number of the plurality of cardiac signal segments.

24 . The method of claim 18 , wherein determining the tachyarrhythmia evidence in the first cardiac signal segment comprises:

identifying signal pulse peaks from the first cardiac signal segment;

determining peak intervals between the identified signal pulse peaks; and

determining that the peak intervals meet a tachyarrhythmia rate threshold.

25 . The method of claim 18 , wherein determining the tachyarrhythmia evidence in the first cardiac signal segment comprises:

determining at least one of:

a low slope content from the first cardiac signal segment;

a spectral width from the first cardiac signal segment; and

a mean period from the first cardiac signal segment;

determining that at least one of the low slope content, the spectral width and the mean period meet tachyarrhythmia evidence criteria; and

determining the tachyarrhythmia evidence in the first cardiac signal segment in response to the at least one of the low slope content, the spectral width and the mean period meeting the tachyarrhythmia evidence criteria.

26 . The method of claim 18 , wherein determining the tachyarrhythmia evidence in the first cardiac signal segment comprises:

determining a spectral width from the cardiac signal segment;

determining a mean period from the cardiac signal segment;

determining that the mean period meets a first threshold;

determining that a ratio of the spectral width and the mean period meets a second threshold; and

determining the tachyarrhythmia evidence in the first cardiac signal segment based on the mean period meeting the first threshold and the ratio of the spectral width and the mean period meeting the second threshold.

27 . The method of claim 18 , further comprising:

receiving a second cardiac signal segment from the at least one cardiac electrical signal sensed after delaying the pending pacing pulse;

determining no tachyarrhythmia evidence in the second cardiac signal segment; and

delivering the delayed pending pacing pulse in response to determining no tachyarrhythmia evidence in at least the second cardiac signal segment.

28 . The method of claim 18 , further comprising:

receiving a second cardiac signal segment from the at least one cardiac electrical signal;

determining an amplitude metric from the second cardiac signal segment;

determining that the amplitude metric is less than an amplitude threshold; and

determining no tachyarrhythmia evidence in the second cardiac signal segment in response to the amplitude metric being less than the amplitude threshold; and

delivering the delayed pending pacing pulse in response to determining no tachyarrhythmia evidence in at least the second cardiac signal segment.

29 . The method of claim 18 , further comprising:

receiving a second cardiac signal segment from the at least one cardiac electrical signal;

determining at least one noise metric from the second cardiac signal segment;

determining no tachyarrhythmia evidence in second cardiac signal segment based on the at least one noise metric; and

delivering the delayed pending pacing pulse in response to determining no tachyarrhythmia evidence in at least the second cardiac signal segment.

30 . The method of claim 18 , further comprising:

delaying the pending pacing pulse by setting a first delay interval in response to the determining tachyarrhythmia evidence in at least the first cardiac signal segment;

receiving a second cardiac signal segment from the at least one cardiac electrical signal sensed during the first delay interval;

determining tachyarrhythmia evidence in the second cardiac signal segment; and

delaying the pending pacing pulse by setting a second delay interval in response to determining the tachyarrhythmia evidence in at least the second cardiac signal segment.

31 . The method of claim 18 , further comprising:

delivering a plurality of pacing pulses;

starting a plurality of pacing escape intervals comprising the first pacing escape interval, wherein each pacing escape interval of the plurality of pacing escape intervals is started in response to a delivered pacing pulse of the plurality of pacing pulses;

receiving a plurality of cardiac signal segments comprising the first cardiac signal segment from the at least one cardiac electrical signal, wherein the plurality of cardiac signal segments are sensed during the plurality of pacing escape intervals;

determining tachyarrhythmia evidence in the plurality of cardiac signal segments; and

delaying the pending pacing pulse scheduled at the expiration of the first pacing escape interval in response to determining the tachyarrhythmia evidence in the plurality of cardiac signal segments.

32 . The method of claim 18 , further comprising:

determining that a maximum pacing delay of the pending pacing pulse is reached; and

delivering the pending pacing pulse in response to the maximum pacing delay being reached.

33 . The method of claim 18 , further comprising determining the tachyarrhythmia evidence without detecting a tachyarrhythmia based on the first cardiac signal segment.

34 . The method of claim 18 , further comprising:

detecting a tachyarrhythmia from the at least one cardiac electrical signal after delaying the pending pacing pulse;

cancelling the pending pacing pulse in response to detecting the tachyarrhythmia; and

delivering a tachyarrhythmia therapy in response to detecting the tachyarrhythmia.

35 . A non-transitory, computer readable medium storing a set of instructions that, when executed by a control circuit of a medical device having a therapy delivery circuit, cause the medical device to:

sense at least one cardiac electrical signal;

schedule a pending pacing pulse for delivery by the therapy delivery circuit by starting a pacing escape interval;

receive a cardiac signal segment from the at least one cardiac electrical signal sensed during the pacing escape interval;

determine tachyarrhythmia evidence in the cardiac signal segment by determining a at least one tachyarrhythmia morphology metric from the first cardiac signal segment; and

delay the pending pacing pulse scheduled for delivery by the therapy delivery circuit at an expiration of the pacing escape interval in response to determining the tachyarrhythmia evidence in at least the cardiac signal segment.

Assignments (3)

Continuity (2)

References Cited (34)